BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6988454)

  • 1. Reduced pancreatic polypeptide secretion in obese subjects.
    Marco J; Zulueta MA; Correas I; Villanueva ML
    J Clin Endocrinol Metab; 1980 Apr; 50(4):744-7. PubMed ID: 6988454
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance.
    Glaser B; Zoghlin G; Pienta K; Vinik AI
    Horm Metab Res; 1988 May; 20(5):288-92. PubMed ID: 3042579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a gastric partitioning operation for morbid obesity on the secretion of gastric inhibitory polypeptide and pancreatic polypeptide.
    Amland PF; Jorde R; Kildebo S; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1984 Sep; 19(6):857-61. PubMed ID: 6393318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating amino acids and pancreatic endocrine function after ingestion of a protein-rich meal in obese subjects.
    Schmid R; Schusdziarra V; Schulte-Frohlinde E; Maier V; Classen M
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1106-10. PubMed ID: 2656733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting and postprandial plasma pancreatic polypeptide (PP) levels in obesity.
    Jorde R; Burhol PG
    Int J Obes; 1984; 8(5):393-7. PubMed ID: 6394520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of physical training on insulin, connecting peptide (C-peptide), gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) levels in obese subjects.
    Krotkiewski M; Björntorp P; Holm G; Marks V; Morgan L; Smith U; Feurle GE
    Int J Obes; 1984; 8(3):193-9. PubMed ID: 6378815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal GIP, PP and insulin levels in morbid obesity before and after stapled gastric partitioning with gastro-gastrostomy.
    Amland PF; Jorde R; Giercksky KE; Burhol PG
    Int J Obes; 1984; 8(2):117-22. PubMed ID: 6373640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome.
    Zipf WB; O'Dorisio TM; Cataland S; Dixon K
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1074-80. PubMed ID: 6352724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid suppression of pancreatic and pituitary hormones: pancreatic polypeptide, growth hormone, and prolactin.
    Lantigua RA; Streck WF; Lockwood DH; Jacobs LS
    J Clin Endocrinol Metab; 1980 Feb; 50(2):298-303. PubMed ID: 6986394
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal ingestion and modified sham feeding in lean and obese persons.
    Lieverse RJ; Masclee AA; Jansen JB; Lamers CB
    Int J Obes Relat Metab Disord; 1994 Feb; 18(2):123-7. PubMed ID: 8148926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome.
    Zipf WB; O'Dorisio TM; Cataland S; Sotos J
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1264-6. PubMed ID: 7014602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic polypeptide response to exercise. Effect of alanine and glucose ingestion in carbohydrate-starved athletes.
    Koeslag JH; Levinrad LI; Klaff LJ
    S Afr Med J; 1985 Jun; 67(22):884-7. PubMed ID: 3890217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose, insulin, gastric inhibitory polypeptide, and pancreatic polypeptide responses to polycose during pregnancy.
    Philipson EH; Rossi KQ; Isaac RM; Kalhan SC
    Obstet Gynecol; 1992 Apr; 79(4):592-6. PubMed ID: 1553183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone suppression of pancreatic polypeptide secretion.
    Zipf WB; Kelch RP; Floyd JC; Hopwood NJ
    J Clin Endocrinol Metab; 1981 Sep; 53(3):574-9. PubMed ID: 7021581
    [No Abstract]   [Full Text] [Related]  

  • 15. Low plasma levels of pancreatic polypeptide in obesity.
    Lassmann V; Vague P; Vialettes B; Simon MC
    Diabetes; 1980 Jun; 29(6):428-30. PubMed ID: 7380112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerulein-induced pancreatic polypeptide secretion. Its inhibition by atropine and its possible role in regulating gallbladder relaxation.
    Tsuda K; Seino Y; Sakurai H; Seino S; Takemura J; Kuzuya H; Adachi H; Imura H
    Am J Gastroenterol; 1980 Oct; 74(4):355-8. PubMed ID: 7006382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired pancreatic polypeptide response to insulin hypoglycemia in obese subjects.
    Lassmann V; Cabrerizzo Garcia L; Vialettes B; Vague P
    Horm Metab Res; 1985 Dec; 17(12):663-6. PubMed ID: 3002934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control.
    Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Holst JJ; Hilsted L; Hellström PM
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5241-6. PubMed ID: 15998783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
    Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L
    J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex difference in the sensitivity of the human pancreatic polypeptide cell to autonomic nervous stimulation in man.
    Valtysson G; Vinik AI; Glaser B; Zohglin GN; Floyd JC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):21-5. PubMed ID: 6336619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.